217 related articles for article (PubMed ID: 23214280)
1. Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection.
Kaczka K; Mikosiński S; Fendler W; Celnik A; Pomorski L
Adv Clin Exp Med; 2012; 21(2):169-78. PubMed ID: 23214280
[TBL] [Abstract][Full Text] [Related]
2. Can procalcitonin be useful for medullary thyroid cancer?
Kaczka K; Mikosiński S; Fendler W; Jałocha-Kaczka A; Pomorski L
Endokrynol Pol; 2010; 61(5):430-6. PubMed ID: 21049453
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.
Algeciras-Schimnich A; Preissner CM; Theobald JP; Finseth MS; Grebe SK
J Clin Endocrinol Metab; 2009 Mar; 94(3):861-8. PubMed ID: 19088163
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules.
Giovanella L; Verburg FA; Imperiali M; Valabrega S; Trimboli P; Ceriani L
Clin Chem Lab Med; 2013 Jul; 51(7):1477-81. PubMed ID: 23314540
[TBL] [Abstract][Full Text] [Related]
5. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
Lim SK; Guéchot J; Vaubourdolle M
Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma.
Bolko P; Manuszewska-Jopek E; Michałek K; Waśko R; Jaskuła M; Sowiński J
Arch Immunol Ther Exp (Warsz); 2003; 51(6):415-9. PubMed ID: 14692663
[TBL] [Abstract][Full Text] [Related]
7. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer.
Kratzsch J; Petzold A; Raue F; Reinhardt W; Bröcker-Preuss M; Görges R; Mann K; Karges W; Morgenthaler N; Luster M; Reiners C; Thiery J; Dralle H; Fuhrer D
Clin Chem; 2011 Mar; 57(3):467-74. PubMed ID: 21159900
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.
Giovanella L; Imperiali M; Piccardo A; Taborelli M; Verburg FA; Daurizio F; Trimboli P
Eur J Clin Invest; 2018 Jun; 48(6):e12934. PubMed ID: 29635700
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
[TBL] [Abstract][Full Text] [Related]
10. Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
J Clin Endocrinol Metab; 2014 Aug; 99(8):2986-94. PubMed ID: 24840813
[TBL] [Abstract][Full Text] [Related]
11. Clinical performance of calcitonin and procalcitonin Elecsys
Giovanella L; Fontana M; Keller F; Verburg FA; Ceriani L
Clin Chem Lab Med; 2021 Mar; 59(4):743-747. PubMed ID: 33085633
[TBL] [Abstract][Full Text] [Related]
12. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer.
Walter MA; Meier C; Radimerski T; Iten F; Kränzlin M; Müller-Brand J; de Groot JW; Kema IP; Links TP; Müller B
Cancer; 2010 Jan; 116(1):31-40. PubMed ID: 19890958
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.
Trimboli P; Seregni E; Treglia G; Alevizaki M; Giovanella L
Endocr Relat Cancer; 2015 Jun; 22(3):R157-64. PubMed ID: 25934688
[TBL] [Abstract][Full Text] [Related]
15. Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease.
Rink T; Truong PN; Schroth HJ; Diener J; Zimny M; Grünwald F
Thyroid; 2009 Apr; 19(4):327-32. PubMed ID: 19355822
[TBL] [Abstract][Full Text] [Related]
16. Macrocalcitonin Is a Novel Pitfall in the Routine of Serum Calcitonin Immunoassay.
Alves TG; Kasamatsu TS; Yang JH; Meneghetti MC; Mendes A; Kunii IS; Lindsey SC; Camacho CP; Dias da Silva MR; Maciel RM; Vieira JG; Martins JR
J Clin Endocrinol Metab; 2016 Feb; 101(2):653-8. PubMed ID: 26647152
[TBL] [Abstract][Full Text] [Related]
17. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
[TBL] [Abstract][Full Text] [Related]
18. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin precursor levels in human medullary thyroid carcinoma.
Bihan H; Becker KL; Snider RH; Nylen E; Vittaz L; Lauret C; Modigliani E; Moretti JL; Cohen R
Thyroid; 2003 Aug; 13(8):819-22. PubMed ID: 14558925
[TBL] [Abstract][Full Text] [Related]
20. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]